Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
IPO Year: 2015
Exchange: NYSE
Website: teladochealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/25/2025 | $10.00 | Neutral | Mizuho |
| 11/15/2024 | $14.00 | Buy | Goldman |
| 9/17/2024 | $8.00 → $10.00 | Hold | Jefferies |
| 2/29/2024 | $22.00 | Overweight | Cantor Fitzgerald |
| 2/26/2024 | $17.00 | Market Perform | Leerink Partners |
| 1/17/2024 | $33.00 → $22.00 | Buy → Neutral | DA Davidson |
| 1/3/2024 | $26.00 | Overweight | Barclays |
| 4/12/2023 | $25.00 | Equal-Weight | Stephens |
| 2/23/2023 | $34.00 | Market Perform → Outperform | SVB Securities |
| 10/24/2022 | Sell → Neutral | Guggenheim |
10-Q - Teladoc Health, Inc. (0001477449) (Filer)
8-K - Teladoc Health, Inc. (0001477449) (Filer)
SCHEDULE 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
8-K - Teladoc Health, Inc. (0001477449) (Filer)
144 - Teladoc Health, Inc. (0001477449) (Subject)
SD - Teladoc Health, Inc. (0001477449) (Filer)
8-K - Teladoc Health, Inc. (0001477449) (Filer)
SCHEDULE 13G - Teladoc Health, Inc. (0001477449) (Subject)
DEFA14A - Teladoc Health, Inc. (0001477449) (Filer)
10-Q - Teladoc Health, Inc. (0001477449) (Filer)
Fastest customizable press release news feed in the world
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery. Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector. With over 300 virtual specialists in over 30 specialties, supporting both GP-referred appointments as well as providing virtual care services to public hospitals across Australia, Telecare helps reduce patient wait times and increases access to speciality care in underserved areas. Teladoc Health is the global
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024"). Highlights Second Quarter 2025 revenue of $631.9 million, down 2% year-over-yearSecond Quarter 2025 net loss of $32.7 million, or $0.19 per shareSecond Quarter 2025 adjusted EBITDA of $69.3 million, down 23% year-over-yearIntegrated Care segment revenue of $391.5 million, up 4% year-over-year, and adjusted EBITDA margin of 14.7%BetterHelp segment rev
Series B led by Touring Capital will propel Wingspan's mission to make flexible work effortless; launch of Wingspan Embed brings comprehensive contractor management to HR platforms NEW YORK, July 29, 2025 /PRNewswire/ -- Wingspan, the first modern payroll platform purpose-built for contractor management, announced that it has raised $24 million in Series B funding led by Touring Capital, bringing its total capital raised to $54 million. Existing investors Andreessen Horowitz, Long Journey Ventures, Distributed Ventures, Company Ventures, and 186 Ventures also participated. Wi
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 606269. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=85796. A live audio webcast will also be available online at https://
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the launch of Wellbound, a bold new employee assistance program (EAP) designed to empower a more engaged, healthier workforce. The new program, purpose-built for the company's employer and health plan clients in the U.S., leverages Teladoc Health's unmatched scale, clinical product portfolio and consumer engagement expertise to help organizations create a powerful "on-ramp" for long-term employee wellness. Though 89% of large employers have an EAP, many aren't getting the full value from their investment. Employees often face a fragmented, disjointed experience when
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations. About Teladoc HealthTeladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses propri
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in connection with commencing employment, two new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 80,000 shares of Teladoc Health's common stock, par value $0.001 per share. The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The awards were approv
USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 6, 2025 /PRNewswire/ -- Healthcare is quickly evolving into a digital-first operation, where top executives in the sector are doubling down on artificial intelligence, automation and analytics to reduce costs and improve billing accuracy. This is according to results of a survey from Everest Group (and supported by Omega Healthcare), which showed 85% of senior healthcare executives believe AI will improve efficiencies over the next five years. Now that multitasking AI Agents are being referred to as hospitals' newest "employees", AI-powered electronic noses are detecting scents for health and enviro
PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in connection with the acquisition of Uplift Health Technologies, Inc., four employees of Uplift Health were granted awards of restricted stock units covering an aggregate of 215,028 shares of Teladoc Health's common stock, par value $0.001 per share ("Common Stock"). The restricted stock units vest, based on continued service to Teladoc Health, over two or three years. Also, effective May 1, 2025, in connection with commencing employment, an additional new non-executive empl
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Mizuho initiated coverage of Teladoc with a rating of Neutral and set a new price target of $10.00
Goldman initiated coverage of Teladoc with a rating of Buy and set a new price target of $14.00
Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously
Cantor Fitzgerald initiated coverage of Teladoc with a rating of Overweight and set a new price target of $22.00
Leerink Partners initiated coverage of Teladoc with a rating of Market Perform and set a new price target of $17.00
DA Davidson downgraded Teladoc from Buy to Neutral and set a new price target of $22.00 from $33.00 previously
Barclays initiated coverage of Teladoc with a rating of Overweight and set a new price target of $26.00
Stephens initiated coverage of Teladoc with a rating of Equal-Weight and set a new price target of $25.00
SVB Securities upgraded Teladoc from Market Perform to Outperform and set a new price target of $34.00
Guggenheim upgraded Teladoc from Sell to Neutral
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
Live Leadership Updates
Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,
After spending two decades successfully scaling multiple healthcare technology companies, Perez joins Big Health to accelerate the commercial coverage and reimbursement for digital therapeutics Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced the appointment of Gabriela Perez as Chief Commercial Officer. In her new role, Perez will oversee Big Health's global commercial growth and strategy, including sales, client management, strategic partnerships, and new markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220203005297/en/Big Health Chief Commercial Office
BRISBANE, Calif., April 14, 2021 /PRNewswire/ -- Caption Health, a leading medical artificial intelligence (AI) company driving better health outcomes by increasing access to ultrasound, announced today that it has appointed Steve Cashman as its new President and Chief Executive Officer, effective immediately. Cashman joins Caption Health after serving as Chief Commercial Officer at InTouch Health, which was acquired by Teladoc (NYSE:TDOC) in 2020. At InTouch, Cashman oversaw the company's domestic and global sales, as well as product, marketing, customer service and clinical
Live finance-specific insights
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery. Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector. With over 300 virtual specialists in over 30 specialties, supporting both GP-referred appointments as well as providing virtual care services to public hospitals across Australia, Telecare helps reduce patient wait times and increases access to speciality care in underserved areas. Teladoc Health is the global
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024"). Highlights Second Quarter 2025 revenue of $631.9 million, down 2% year-over-yearSecond Quarter 2025 net loss of $32.7 million, or $0.19 per shareSecond Quarter 2025 adjusted EBITDA of $69.3 million, down 23% year-over-yearIntegrated Care segment revenue of $391.5 million, up 4% year-over-year, and adjusted EBITDA margin of 14.7%BetterHelp segment rev
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 606269. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=85796. A live audio webcast will also be available online at https://
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services. The acquisition supports the company's strategy to further enhance its leadership position in virtual mental health, including the ability for consumers served by its BetterHelp segment to access benefits coverage for mental health services. UpLift serves the health plan market and has arrangements covering over 100 million lives, a network of over 1,500 mental health professionals, important capabilities and a talent
PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 309585. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=81196. A live audio webcast will also be available online at h
PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 ("Full Year 2024") and three months ended December 31, 2024 ("Fourth Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 ("Full Year 2023") and three months ended December 31, 2023 ("Fourth Quarter 2023"). Full Year and Fourth Quarter 2024 Highlights Full Year 2024 revenue of $2,569.6 million, down 1% year-over-year, and Fourth Quarter 2024 revenue of $640.5 million, down 3% year-over-yearFull Year 2024 net loss of
PURCHASE, NY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release fourth quarter 2024 results on Wednesday, February 26, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 259200. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=72270. A live audio webcast will also be available online at http
PURCHASE, NY, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended September 30, 2024 ("Third Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2023 ("Third Quarter 2023"). Third Quarter 2024 Highlights Third Quarter 2024 revenue of $640.5 million, down 3% year-over-yearThird Quarter 2024 net loss of $33.3 million, or $0.19 per shareThird Quarter 2024 adjusted EBITDA of $83.3 million, down 6% year-over-yearIntegrated Care segment revenue of $383.7 million, up 2% year-over-year, and adjusted EBIT
PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=72270. A live audio webcast will also be available o
This live feed shows all institutional transactions in real time.
SC 13G - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)